PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
50.37
ESG score 80-90% of VKTX's 56.58. Walter Schloss would scrutinize governance quality and regulatory exposure.
43.48
Environmental score 80-90% of VKTX's 48.96. Walter Schloss would scrutinize carbon exposure and transition planning.
55.43
Social score 90-95% of VKTX's 60.46. Bill Ackman would demand clear social improvement catalysts.
52.20
Governance score 80-90% of VKTX's 60.31. Walter Schloss would scrutinize management accountability and board independence.